Replies to post #1457 on Momenta Pharmaceuticals, Inc. (MNTA)

[rwwine]

"Can it be attributed to the non approval by the FDA for M Copax?"

I firmly beleive it has nothing to do with M-Copax. Most investors I think don't expect M-Copax to be approved any time soon by the FDA.

[flatlander_60048]

The relative timing of MNTA's downward slide is clearly tied to TEVA's press releases on T-enox. Both the big sell off in July-August and last weeks minor deficiency letter, have had a significant share price erosion effect.

What is amazing is that the same essential news by Teva can bring
MNTA down to its pre m-enox share price without damaging the credibility of Teva.


In July it was "any day"
In OCT it was by year end
In January it was "minor deficiency"

I wouldn't have thought to get more mileage from the same empty prognostications but they do.

FL